Minoxidil/Biotin/Spironolactone 1 — Class I drug recall D-1363-2020
Terminated recall by MasterPharm LLC, reported 2020-07-08, distributed in FL, MD. Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.
| Recall number | D-1363-2020 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | MasterPharm LLC, South Richmond Hill, NY, United States |
| Recall initiated | 2020-06-09 |
| Classified | 2020-06-26 |
| Reported by FDA | 2020-07-08 |
| Terminated | 2023-10-16 |
| Distributed | FL, MD |
| Quantity | 300 capsules |
| Reason classes | potency |
| Expiration dates | 2020-07-07 |
Product
Minoxidil/Biotin/Spironolactone 1.25/5/25 mg capsule, 90 capsules per bottle, This is a compounded drug not for resale, Store at room temperature, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.
Reason for recall
Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1363-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.